Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$55.1B
195M shares
52-week range
$244.82 – $377.54
33% from low
Sector
WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Exchange
NYSE
CS
Borrow rate
0.41%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $167.94B | $179.59B | $189.89B | $213.99B | $238.59B | $262.17B | $293.96B | $321.33B |
| Cost of revenue | $163.83B | $175.06B | $185.10B | $207.72B | $230.99B | $254.42B | $285.26B | $311.19B |
| Gross profit | $4.11B | $4.53B | $4.79B | $6.27B | $7.60B | $7.76B | $8.70B | $10.14B |
| Gross margin | 2.4% | 2.5% | 2.5% | 2.9% | 3.2% | 3.0% | 3.0% | 3.2% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $1.65B | $1.87B | $2.02B | $2.68B | $2.75B | $2.45B | $3.04B | $3.65B |
| EBITDA | $1.87B | $1.65B | −$4.73B | $2.91B | $3.11B | $3.41B | $3.36B | $3.74B |
| Net income | $1.66B | $855.4M | −$3.40B | $1.54B | $1.70B | $1.75B | $1.51B | $1.55B |
| Net margin | 1.0% | 0.5% | -1.8% | 0.7% | 0.7% | 0.7% | 0.5% | 0.5% |
| EPS (diluted) | 7.53 | 4.04 | -16.60 | 7.39 | 8.04 | 8.53 | 7.53 | 7.96 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $337.9B | $17.79 | $17.52–$17.88 | 7 |
| 2027 | $356.8B | $19.81 | $19.30–$20.25 | 8 |
| 2028 | $378.8B | $21.98 | $20.06–$24.54 | 3 |
| 2029 | $403.3B | $25.12 | $24.65–$25.57 | 1 |
Forward consensus · source: Financial Modeling Prep
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
www.cencora.comNo one on the platform currently holds COR.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-12-31 | 121,940 | $41.2M |
| Bridgewater Associatesas of 2026-03-31 | 14,227 | $4.5M |
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-15 | $0.6000 | 2026-06-01 |
| 2026-02-13 | $0.6000 | 2026-03-02 |
| 2025-11-14 | $0.6000 | 2025-12-01 |
| 2025-08-15 | $0.5500 | 2025-09-03 |
| 2025-05-16 | $0.5500 | 2025-06-02 |
| 2025-02-14 | $0.5500 | 2025-03-03 |
| 2024-11-15 | $0.5500 | 2024-11-29 |
| 2024-08-09 | $0.5100 | 2024-08-26 |
| 2024-05-09 | $0.5100 | 2024-05-24 |
| 2024-02-08 | $0.5100 | 2024-02-26 |
No one on the platform has traded COR yet.
| $27M |
| — |
| CVETCovetrus, Inc. | $20.99 | +0.00% | $0 | — |
| GALNFGalenica AG | $115.00 | +0.00% | $5.7B | — |
Source: Financial Modeling Prep · peers by sector/industry
| 2023-11-10 |
| $0.5100 |
| 2023-11-27 |
| 2023-08-10 | $0.4850 | 2023-08-28 |
| Execution date | Ratio |
|---|---|
| 2009-06-16 | 2-for-1 |
| 2005-12-29 | 2-for-1 |
Trading at 33.5× earnings vs its 26.6× historical median P/E.
Fair value ≈ $229.45 · price $288.42 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$OTLK does anyone remember if $MCK had been mentioned before? $COR isn’t a surprise. Any guesses on potential other channel #partners? Good luck $OTLK on PDUFA Wednesday 7/29/26!
View on StockTwits ↗$COR Current Stock Price: $279.51 Contracts to trade: $280.0 COR Jul 17 2026 Call Entry: $7.80 Exit: $14.16 ROI: 82% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
View on StockTwits ↗$COR Will this go up or come down to where it was before?
View on StockTwits ↗#INSIDERS $COR Director bought 4,000 shares at $274.19 worth approximately $1.1 mln (transaction date 6/18). $LOVE President and one (1) Director bought 31,720 shares combined at $14.105 - $14.83 worth approximately $465K (transaction dates 6/18-6/22). $MSTR Chief Executive Officer bought 11,000 shares of Series A Perpetual Stretch Preferred Stock worth approximately $999K (transaction date 6/22). $JPM General Counsel sold 5,467 shares at $330.7337 worth approximately $1.8 mln (transaction date 6/22). $LWAY 10% owner sold 50,000 shares at $26.00 - $26.99 worth approximately $1.3 mln (transaction date 6/22).
View on StockTwits ↗$COR https://youtu.be/yipav-YwAsc?is=8OhThthkNnCK0ar5
View on StockTwits ↗$COR $1.1 million insider purchase: https://filingtracker.ai/filing/1140859/0001202358-26-000006
View on StockTwits ↗@You2222 @HT_LABS Lol uh $COR ?????? Any DD at all? Or just fuddy fud ya fudster lol 😆 😂
View on StockTwits ↗@You2222 This might be a different type than expected-but maybe try clicking control find: partner or partnership at the first link? $COR $OTLK https://www.cencora.com/resources/pharma/emerging-biopharma-benefits-from-international-commercialization Coincidence? https://www.cencora.com/newsroom/cencora-to-invest-1-billion-in-us-distribution-network
View on StockTwits ↗$COR is an absolute cash-generating machine! Cencora just updated their fiscal 2026 outlook, raising EPS guidance and announcing a massive new $2.0 billion share repurchase program! The board is aggressively eating up their own float, and the market is officially waking up to the value here. Taking a look at the daily chart, this is a textbook reversal setup! Price found a hard bottom near the $242 level and is now violently hooking up with a powerful momentum shift off the lows. The tape has flipped, and it's coiling incredibly tight right below immediate overhead resistance! 📊🐋 🐂 Bulls: Need a decisive break and hold above the $271.00 resistance zone to spark a structural squeeze toward the $290 level! 🚀 🐻 Bears: A flush below the $250.00 support base traps the early dip buyers and resumes the heavy downtrend. 🛑 #COR #StockMarket #SwingTrading #hovdid
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.